Molecular Basis of Mitochondrial Pathology (Volume 17) (Current Topics in Bioenergetics, Volume 17)
Released: Nov 24, 1994
Publisher: Academic Press
Format: Hardcover, 254 pages
Related ISBN: 9780121525156
Description:
The field of mitochondrial diseases is currently one of the rapidly growing fields of research in cell and molecular biology. This volume encompasses the latest development in this field of research. The chapters cover topics in a wide range of disciplines including biophysics, biochemistry, cell and molecular biology, molecular genetics, and clinical medicine. Summarizes growing evidence of the role of mitochondria in a large number of pathological conditionsBrings together different approaches toward understanding mitochondria diseasesMolecular and cellular biologyClinical physiology and medicineDetails the crucial role this organelle plays in genetic regulation of various biological functions.
Best prices to buy, sell, or rent ISBN 9780121525170
Frequently Asked Questions about Molecular Basis of Mitochondrial Pathology (Volume 17) (Current Topics in Bioenergetics, Volume 17)
You can buy the Molecular Basis of Mitochondrial Pathology (Volume 17) (Current Topics in Bioenergetics, Volume 17) book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .
The price for the book starts from $8.82 on Amazon and is available from 1 sellers at the moment.
If you’re interested in selling back the Molecular Basis of Mitochondrial Pathology (Volume 17) (Current Topics in Bioenergetics, Volume 17) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Molecular Basis of Mitochondrial Pathology (Volume 17) (Current Topics in Bioenergetics, Volume 17) book, the best buyback offer comes from and is $ for the book in good condition.
Not enough insights yet.
Not enough insights yet.